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Parabens are esters of 4-hydroxybenzoic acid 
that are commonly used as anti  microbial pre-
servatives in cosmetics, pharmaceuticals, and 
food or beverage processing (Andersen 2008). It 
is likely that repeated contact with products or 
foods containing parabens leads to widespread 
human exposure through ingestion, inhalation, 
or dermal contact. Methyl paraben (MP), ethyl 
paraben (EP), propyl paraben (PP), and butyl 
paraben (BP) have recently been detected in a 
high proportion of urine samples collected as 
part of a national U.S. survey of exposure to 
environmental chemicals (Calafat et al. 2010).
Parabens are thought to possess low tox-
icity (Golden et al. 2005; Soni et al. 2005). 
However, some parabens may be estrogenic 
in vitro (Routledge et al. 1998), although with 
activity levels several orders of magnitude lower 
than that of estrogen. Recent experimental stud-
ies have reported that certain parabens may also 
act as anti  androgens (Chen et al. 2007; Darbre 
and Harvey 2008; Satoh et al. 2005), and there 
is limited evidence that parabens may affect 
thyroid function (Rousset 1981; Taxvig et al. 
2008; Vo et al. 2010). Several animal studies 
have explored the impacts of parabens on male 
reproductive effects, with some reporting that 
exposure to BP and PP, but not MP, adversely 
affects spermatogenesis and endocrine func-
tion in rats or mice (Kang et al. 2002; Oishi 
2001, 2002a; 2002b; 2004). Conversely, in 
another recent study, Hoberman et al. (2008) 
found no association between MP or BP and 
reproductive markers in rats. Based on these 
limited animal studies, in addition to the obser-
vation that paraben estrogenicity depends on 
the length of the alkyl side chain (Darbre and 
Harvey 2008), the reproductive toxicity poten-
tial of parabens for which widespread human 
exposure has been documented is thought to be 
BP > PP > EP > MP.
To our knowledge, no human studies have 
investigated the association between para-
ben exposure and measures of male repro-
duction. In the present study we assessed 
relation  ships between urinary concentrations 
of several parabens and a range of male repro-
ductive health markers in an ongoing study of 
environmental determinants of reproductive 
health. We also considered the potential for 
inter  actions between parabens and another 
estrogenic xeno  biotic, bisphenol A (BPA), 
for which we recently reported associations 
with reproductive measures in this population 
(Meeker et al. 2010a, 2010b).
Materials and Methods
Participants were male partners in sub  fertile 
couples seeking treatment between 2000 and 
2004 from the Vincent Memorial Obstetrics 
and Gynecology Service. After the study 
procedures were explained and all questions 
answered, subjects signed an informed con-
sent. Men between 18 and 55 years of age 
without post  vasectomy status who presented to 
the Andrology Laboratory were eligible to par-
ticipate. Of those approached, approximately 
65% consented. Most men who declined to 
participate in the study cited lack of time on 
the day of their clinic visit as the reason for not 
participating. The study was approved by the 
human studies institutional review boards of 
MGH, Harvard School of Public Health, the 
Centers for Disease Control and Prevention 
(CDC), and the University of Michigan.
On the day of each subject’s clinic visit, a 
single spot urine sample was collected into a 
sterile polypropylene cup. Because the tempo-
ral reliability of parabens in urine is unknown, 
second and third urine samples were collected 
from a subset of men at subsequent clinic 
visits. These samples were generally collected 
between 1 week and 2 months after the first 
sample. After measuring specific gravity (SG) 
using a handheld refractometer (National 
Instrument Co. Inc., Baltimore, MD), each 
urine sample was divided in aliquots and fro-
zen at –80°C. Samples were shipped on dry 
ice overnight to the CDC, where concentra-
tions of total (free + conjugated) MP, PP, BP, 
and BPA were meas  ured using a modification 
of the approach described by Ye et al. (2006). 
EP was not meas  ured because of low detection 
rates among the U.S. population (Calafat et al. 
2010). The analytical method and results for 
BPA have been previously reported (Meeker 
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Ba c k g r o u n d: Parabens are commonly used as anti  microbial preservatives in cosmetics, 
  pharmaceuticals, and food and beverage processing. Widespread human exposure to parabens has 
been recently documented, and some parabens have demonstrated adverse effects on male reproduc-
tion in animal studies. However, human epidemiologic studies are lacking.
oB j e c t i v e: We investigated relationships between urinary concentrations of parabens and markers 
of male reproductive health in an ongoing reproductive epidemiology study.
Me t h o d s : Urine samples collected from male partners attending an infertility clinic were ana-
lyzed for methyl paraben (MP), propyl paraben (PP), butyl paraben (BP), and bisphenol A (BPA). 
Associations with serum hormone levels (n = 167), semen quality parameters (n = 190), and sperm 
DNA damage measures (n = 132) were assessed using multivariable linear regression.
re s u l t s: Detection rates in urine were 100% for MP, 92% for PP, and 32% for BP. We observed 
no statistically significant associations between MP or PP and the outcome measures. Categories 
of urinary BP concentration were not associated with hormone levels or conventional semen qual-
ity parameters, but they were positively associated with sperm DNA damage (p for trend = 0.03). 
When urinary BPA quartiles were added to the model, BP and BPA were both positively associated 
with sperm DNA damage (p for trend = 0.03). Assessment of paraben concentrations measured on 
repeated urine samples from a subset of the men (n = 78) revealed substantial temporal variability.
co n c l u s i o n s: We found no evidence for a relationship between urinary parabens and hormone 
  levels or semen quality, although intra  individual variability in exposure and a modest sample size 
could have limited our ability to detect subtle relationships. Our observation of a relationship 
between BP and sperm DNA damage warrants further investigation.
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et al. 2010a, 2010b). The conjugated species 
of BPA and parabens were first hydrolyzed 
in 100 µL of urine using β-glucuronidase/
sulfatase (Helix pomatia, H1; Sigma Aldrich, 
St. Louis, MO). The target compounds were 
pre  concentrated by online solid-phase extrac-
tion, separated from other urine components 
by reversed-phase high-performance liquid 
chromatography, and detected by atmo-
spheric pressure chemical ionization/isotope 
dilution/tandem mass spectrometry with 
peak focusing (Ye et al. 2006). The limits of 
detection (LODs) were 1.0 µg/L for MP and 
0.2 µg/L for PP and BP. Low-concentration 
(2.2–9.0 µg/L) and high-concentration   
(10.5–53.8 µg/L) quality control materials 
(QCLs and QCHs, respectively) were prepared 
with pooled human urine that was analyzed 
with standards, reagent blanks, and study sam-
ples. The precision of measure  ments, expressed 
as the relative SD of 55–66 meas  ures, depend-
ing on the analyte, was 5.8–12.1% for QCLs 
and 4.4–5.6% for QCHs. Paraben concentra-
tions were corrected for SG using the formula
  Pc = P[(1.024 – 1)/(SG – 1)],  [1]
where Pc is the SG-adjusted paraben concen-
tration (nanograms per milliliter), P is the 
observed paraben concentration, and SG is 
the specific gravity of the urine sample.
One non  fasting blood sample was drawn 
between 0900 and 1600 hours on the same 
day and time that the first urine sample was 
collected. Blood samples were centrifuged, and 
the resulting serum was stored at –80°C until 
hormone analysis at the MGH Reproductive 
Endocrinology Laboratory. Serum tes-
tosterone, estradiol (E2), sex-hormone– 
binding globulin (SHBG), inhibin B, fol-
licle-stimulating hormone (FSH), luteiniz-
ing hormone (LH), prolactin, free thyroxine 
(T4), total triiodo  thyronine (T3), and thyroid- 
stimulating hormone (TSH) were meas  ured 
using sensitive immuno  assay methods as 
described previously (Meeker et al. 2007). 
The free androgen index (FAI) was calculated 
as the molar ratio of total testosterone to 
SHBG. Free testosterone was also estimated 
using published methods (Vermeulen et al. 
1999). The testosterone:LH ratio, a measure 
of Leydig cell function, was calculated by 
dividing testosterone (nanomoles per liter) 
by LH (international units per liter). The 
FSH:inhibin B and E2:testosterone ratios were 
also calculated as measures of Sertoli cell func-
tion and aromatase activity, respectively.
Onsite at MGH, semen was collected 
from each subject into a sterile plastic speci-
men cup after a recommended abstinence 
period of 48 hr. After liquefaction at 37°C 
for 20–60 min, semen quality parameters 
and motion charac  teris  tics were meas  ured at 
the clinic.
Semen samples were analyzed for sperm 
concentration, motility, and motion param-
eters using a computer-aided semen analyzer 
(CASA; version 10HTM-IVOS; Hamilton-
Thorne Research, Beverly, MA) as previously 
described (Meeker et al. 2004a, 2008). Total 
sperm count (106 per ejaculate) was calculated 
by multiplying sperm concentration (106/mL)   
by semen sample volume (milli  liters). 
Motile sperm was defined as World Health 
Organization (WHO) grade “a” sperm (rap-
idly progressive with a velocity ≥ 25 µm/sec 
at 37°C) plus “b” grade sperm (slow/sluggish 
progressive with a velocity of ≥ 5 µm/sec but 
< 25 µm/sec) (WHO 1999). Of seven CASA 
motion variables meas  ured, we included only 
three in our analy  sis [straight-line velocity 
(VSL), curvilinear velocity (VCL), and lin-
earity (VSL/VCL × 100)] because of a high 
degree of dependence between several of the 
meas  ures (Duty et al. 2004; Meeker et al. 
2004a). Sperm morphology was assessed 
on two slides per specimen (with a mini-
mum of 200 cells assessed per slide) with a 
Nikon microscope using an oil-immersion 
100× objective (Nikon Company, Tokyo, 
Japan). We used strict Kruger scoring criteria 
to classify men as having normal or below 
normal morphology (Kruger et al. 1988).
The remaining unprocessed semen was 
frozen in 0.25 mL cryogenic straws (Cryo Bio 
System, IMV Technologies, San Diego, CA) 
by immersing the straws directly into liq-
uid nitrogen (–196°C). Previous work in our 
laboratory showed that this freezing method 
produced comet assay results that were highly 
correlated with results from fresh, unfrozen 
samples (Duty et al. 2002). Semen samples 
were later analyzed in batches, where straws 
were thawed by gently shaking in a 37°C 
water bath for 10 sec, and the semen was 
immediately processed for the comet assay. 
To assess sperm DNA damage, we followed 
a comet assay procedure that has been pre-
viously described (Duty et al. 2003; Singh 
and Stephens 1998). After lysis, electro-
phoresis, and staining, we meas  ured comet 
extent, tail distributed moment (TDM), and 
percent DNA located in the tail (Tail%) for 
100 sperm in each semen sample using a 
fluorescence microscope and VisComet soft-
ware (Impuls Computergestutzte Bildanalyse 
GmbH, Gilching, Germany). Comet extent 
is a meas  ure of total comet length from the 
beginning of the head to the last visible pixel 
in the tail. Tail% is a measurement of the 
proportion of total DNA that is present in 
the comet tail (i.e., fragmented DNA that 
has migrated away from the comet head). 
TDM is an integrated value that takes into 
account both the distance and intensity of 
comet fragments:
  TDM = Σ(I × X)/ΣI,  [2]
where ΣI is the sum of all intensity values that 
belong to the head, body, or tail and X is the 
x-position of the intensity value.
We performed data analysis using SAS 
(version 9.1; SAS Institute Inc., Cary, NC). In 
preliminary data analysis, paraben concentra-
tions and outcome meas  ures were compared by 
demo  graphic categories and other potentially 
important covariates using appropriate para-
metric or non  parametric tests to investigate the 
potential for confounding. Multivariable linear 
regression was used to explore relationships 
between urinary paraben concentrations and 
hormone levels, semen quality parameters, and 
sperm DNA damage measures. Serum con-
centrations of inhibin B, testosterone, free tes-
tosterone, and E2, along with semen volume, 
sperm motility, morphology, and all sperm 
motion and sperm DNA damage measures, 
closely approximated normality and were used 
in statistical models untransformed. The distri-
bution of sperm count, sperm concentration, 
FSH, LH, SHBG, prolactin, TSH, and all cal-
culated hormone ratios were positively skewed 
and transformed by the natural logarithm (ln) 
for statistical analy  ses. Urinary MP and PP 
concentrations were also ln transformed. For 
PP, MP, and BPA concentrations < LOD, we 
used an imputed value of LOD/2. Because 
of the high proportion of samples with BP 
values < LOD, a three-level ordinal variable 
was formed: all samples with concentrations 
< LOD were assigned to the lowest group, and 
two equally sized groups were formed among 
the samples with detectable concentrations to 
form the median- and high-exposure groups. 
Tests for trend were conducted for ordinal BP 
categories in regression models using integer 
values (0, 1, 2).
Inclusion of covariates in the multi  variable 
models was based on statistical and biologic 
considerations (Kleinbaum et al. 1998). We 
included SG as a continuous variable in all 
models to adjust for urinary dilution. Age and 
body mass index (BMI) were also modeled 
as continuous variables, whereas abstinence 
period was treated as an ordinal categori-
cal variable. Race (white vs. other), smoking 
status (current smoker vs. former or never 
smoker), and timing of the clinic visit (i.e., 
time of collection of urine/blood/semen sam-
ples) by season (winter vs. spring, summer, or 
fall) and by time of day (0900–1259 hours 
vs. 1300–1600 hours) were considered for 
inclusion in the models as dichotomous vari-
ables. Covariates with a p-value < 0.2 in their 
relationship with one or more parabens or at 
least one outcome meas  ure in the preliminary 
bivariate analyses were included in a “full” 
model. Covariates with a p-value > 0.15 in 
full models for all measures within the three 
sets of outcomes (hormone levels, semen 
quality, sperm DNA damage) were removed 
from the final models. Models for all outcome Meeker et al.
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measures within each of the three sets of out-
comes were adjusted for the same covariates 
to maintain consistency. For the dependent 
variables of interest (urinary paraben concen-
trations), we considered p < 0.05 statistically 
significant. Because of the explora  tory nature 
of the analysis, p-values < 0.1 were considered 
statistically suggestive.
Because repeated urine samples were 
available for a subset of the men, two sets 
of models were constructed: a) using only 
urinary paraben concentrations from a single 
urine sample collected on the same day as 
the serum sample; and b) using the geometric 
mean urinary paraben concentration for each 
participant, where between one and three 
values were used to calculate each individual’s 
geometric mean (i.e., the geometric mean for 
men with only one value was equal to that 
single value). In further sensitivity analyses, 
the multi  variable models were rerun after 
excluding men with highly concentrated or 
highly dilute urine samples (SG > 1.03 or 
< 1.01) (Teass et al. 1998), and when using 
SG-corrected paraben concentrations rather 
than uncorrected urinary paraben concentra-
tions but including SG as a covariate. Finally, 
to assess temporal variability in urinary para-
ben concentrations, we calculated Spearman 
correlations for paraben concentrations in the 
first and second urine samples among men 
with two urine samples. Using paraben data 
from all men, we also calculated the intra  class 
correlation coefficient (ICC), which is the 
ratio of between-subject variability to total 
variability (total variability = between-subject 
variability + within-subject variability), using 
SAS PROC MIXED.
Results
Demographic and outcome measure distri-
bution data on the men who participated 
in the study have been described elsewhere 
(Meeker et al. 2010a, 2010b). Briefly, most 
men were white (84%) and were non  smokers 
at the time of the clinic visit (90%). The mean 
(± SD) age and BMI were 36.7 ± 5.4 years 
and 27.4 ± 4.5, respectively. Median (25th, 
75th percentile) values for sperm concentra-
tion, motility, and morphology were 100 mil-
lion (24 million, 145 million) sperm/mL, 
46% (26%, 66%) motile sperm, and 7% 
(3%, 10%) normal sperm, respectively.
Detection rates and distributions of uncor-
rected and SG-corrected urinary paraben 
concentrations from urine samples collected 
from 194 men on the same day as a serum 
sample (hormone levels) and/or semen sample 
(semen quality, sperm DNA damage) are pre-
sented in Table 1. Information on SG was 
missing for four urine samples. We detected 
MP in all samples and at the highest concen-
trations (median = 27.4 µg/L), followed by PP 
(median = 3.5 µg/L). BP was positively associ-
ated with age (Spearman r = 0.16; p = 0.03), 
but MP and PP were not. All three parabens 
were inversely associated with BMI (Spearman 
r, between –0.15 and –0.17; p-values < 0.05). 
Paraben concentrations were not associated 
with smoking status, time of day or season 
of urine sample collection, or duration of 
abstinence before semen sample collection. 
PP concentrations (p < 0.05), but not MP or 
BP concentrations (p > 0.05), were higher in 
non  white men than in white men. MP and 
PP concentrations were strongly correlated 
with one another (r = 0.82; p < 0.0001), and 
both were only weakly to moderately corre-
lated with BP (both r = 0.39; p < 0.0001). 
Spearman correlation coefficients with urinary 
Table 1. Distribution of uncorrected and SG-corrected paraben concentrations in urine (μg/L) collected at 
the initial clinic visit. 
Percent 
detected GM
Percentile
Analyte n 10th 25th 50th 75th 90th 95th Maximum
Uncorrected
MP 194 100 28.6 5.10 11.4 27.4 64.8 191 258 1,080
PP 194 92 3.67 0.40 0.80 3.45 17.1 43.8 95.5 294
BP 194 32 NC < LOD < LOD < LOD 0.30 1.70 4.10 64.5
SG-corrected
MP 190 35.5 6.63 14.4 32.6 85.7 200 340 1,037
PP 190 4.52 0.48 1.07 4.45 20.9 58.9 107 229
BP 190 NC < LOD < LOD < LOD 0.36 1.60 3.73 32.0
GM, geometric mean. Not calculated (NC) because of the high percentage of samples < LOD. For MP, LOD was 1.0 μg/L; 
for both PP and BP, LOD was 0.2 μg/L. 
Table 2. Adjusteda regression coefficients for change in serum hormone level associated with a ln-unit 
increase in urinary concentrations of MP or PP (n = 167).
MP PP
Hormone β-Coefficient (95% CI) p-Value β-Coefficient (95% CI) p-Value
FSH (IU/L)b 0.01 (–0.06 to 0.09) 0.69 0.01 (–0.04 to 0.06) 0.71
LH (IU/L)b 0.02 (–0.04 to 0.09) 0.48 0.01 (–0.03 to 0.05) 0.69
Inhibin B (pg/mL) 2.62 (–8.07 to 13.3) 0.63 –1.15 (–8.35 to 6.06) 0.75
FSH:inhibin B ratiob 0.02 (–0.12 to 0.17) 0.74 0.03 (–0.07 to 0.12) 0.61
T (ng/dL)c 9.23 (–2.98 to 21.5) 0.14 6.82 (–1.36 to 15.0) 0.10
E2 (pg/mL) –0.12 (–1.74 to 1.51) 0.89 –0.01 (–1.10 to 1.08) 0.98
SHBG (nmol/mL)b 0.004 (–0.04 to 0.05) 0.87 0.001 (–0.03 to 0.03) 0.94
FAIb 0.02 (–0.02 to 0.07) 0.31 0.02 (–0.01 to 0.05) 0.14
Free T (ng/dL) 0.21 (–0.08 to 0.52) 0.15 0.13 (–0.07 to 0.33) 0.20
T:LH ratiob 0.004 (–0.07 to 0.08) 0.92 0.01 (–0.04 to 0.06) 0.56
E2:T ratiob –0.05 (–0.12 to 0.03) 0.20 –0.03 (–0.08 to 0.02) 0.31
Prolactin (ng/mL)b –0.01 (–0.07 to 0.04) 0.60 0.01 (–0.03 to 0.04) 0.65
Free T4 (ng/dL) –0.01 (–0.03 to 0.02) 0.67 0.01 (–0.01 to 0.03) 0.47
Total T3 (ng/mL) 0.005 (–0.02 to 0.02) 0.63 0.003 (–0.01 to 0.02) 0.64
TSH (μIU/mL)b –0.07 (–0.15 to 0.01) 0.08 –0.02 (–0.07 to 0.03) 0.46
Abbreviations: CI, confidence interval, T, testosterone.
aAdjusted for SG, age, BMI, current smoking status, and time of day of blood/urine sample collection. bModel included 
ln-transformations for parabens and hormones; inhibin B, testosterone, free T, E2, free T4, and total T3 were modeled 
untransformed. cModels for T also adjusted for ln-transformed SHBG. 
Table 3. Adjusteda linear regression coefficients for change in semen quality or sperm measures associ-
ated with a ln-unit increase in urinary concentrations of MP or PP (n = 190).
MP PP
Semen/sperm measure β-Coefficient (95% CI) p-Value β-Coefficient (95% CI) p-Value
Semen quality
Total count (106)b –0.07 (–0.25 to 0.11) 0.42 –0.05 (–0.17 to 0.08) 0.45
Concentration (106/mL)b –0.08 (–0.24 to 0.08) 0.33 –0.06 (–0.17 to 0.05) 0.27
Motility (% motile) –0.48 (–3.26 to 2.30) 0.73 –0.20 (–2.09 to 1.69) 0.84
Morphology (% normal) 0.04 (–0.52 to 0.60) 0.89 0.14 (–0.24 to 0.52) 0.46
Sperm motion
VSL (μm/sec) 0.001 (–1.72 to 1.73) 1.00 –0.05 (–1.22 to 1.12) 0.93
VCL (μm/sec) –0.17 (–3.09 to 2.75) 0.91 –0.18 (–2.17 to 1.80) 0.86
Linearity (%) –0.25 (–2.00 to 1.50) 0.78 0.002 (–1.19 to 1.19) 1.00
DNA damagec
Comet extent (μm) 0.67 (–6.10 to 7.45) 0.84 –1.19 (–5.61 to 3.22) 0.59
TDM (μm) –1.31 (–3.58 to 0.95) 0.25 –1.42 (–2.88 to 0.04) 0.06
Tail% 2.35 (–0.16 to 4.85) 0.07 0.67 (–0.98 to 2.32) 0.42
CI, confidence interval.
aAdjusted for SG, age, BMI, abstinence period, current smoking, and time of day of urine/semen sample collection. 
bModel included ln-transformations of parabens, sperm count, and sperm concentration. cn = 132. Parabens and markers of male reproductive health
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BPA were 0.29 for MP (p < 0.0001), 0.18 for 
PP (p = 0.01), and 0.11 for BP (p = 0.13).
In addition to the 194 urine samples col-
lected at the same visit as serum/semen sample 
collection, a second urine sample was later 
collected from 78 of the men, and a third 
urine sample was collected from 4 men. The 
amount of time between consecutive urine 
samples ranged from 3 to 75 days, with a 
median (25th, 75th percentile) of 29 (27, 34) 
days. Among the 78 men who provided two 
urine samples, paraben concentrations in the 
first and second urine samples were weakly 
correlated for MP (Spearman r = 0.36; 
p = 0.003) and PP (r = 0.25; p = 0.03), and 
moderately correlated for BP (r = 0.46; 
p < 0.0001). However, these values increased 
when using SG-corrected concentrations 
(r = 0.46, 0.31, and 0.58, respectively). When 
considering all 272 urine samples with para-
ben concentrations measured, the ICC was 
0.26 (SG-corrected, 0.35) for MP and 0.18 
(SG-corrected, 0.26) for PP. We did not cal-
culate ICC for BP because of the high pro-
portion of non  detectable concentrations. For 
comparison, the ICC for BPA in these samples 
was 0.08 (SG-corrected, 0.13).
Urinary paraben, covariate, and outcome 
data were available from 167 men for hormone 
levels, 190 men for semen quality parame-
ters, and 132 men for sperm DNA damage   
measures. In exploratory bivariate analyses, we 
found no statistically significant correlations 
between uncorrected or SG-corrected con-
centrations of MP or PP and hormone levels, 
semen quality parameters, or sperm DNA 
damage (data not shown). We also found no 
associations in multi  variable linear regression 
models adjusted for age, BMI, smoking, time 
of day, and duration of abstinence (Tables 2 
and 3), although we found a suggestive 
inverse relationship between MP and TSH 
(Table 2), a suggestive positive association 
between MP and Tail% (Table 3), and a sug-
gestive inverse relationship between PP and 
TDM (Table 3). Results were similar when 
we also considered repeated urinary paraben 
concentrations meas  ured in samples collected 
weeks or months after the initial urine sam-
ple, although the relationships between MP 
and TSH and Tail%, and between PP and 
TDM, were somewhat weakened (i.e., regres-
sion coefficients were closer to zero; data not 
shown). Our findings were also consistent 
when using SG-corrected paraben concentra-
tions in the models, as well as when excluding 
concentrated or diluted urine samples with 
SG > 1.03 or < 1.01 (data not shown).
Aside from a suggestive positive association 
with FAI, categories of urinary BP were also 
not associated with hormone levels or semen 
quality parameters (Table 4). However, BP 
categories were associated with a dose-related 
increase in Tail% (p for trend = 0.03). Overall, 
Measure
β-Coefficient  
(95% CI)
Serum hormone levelsa
FSH (IU/L)b 0
< 0.2 μg/L –0.04 (–0.29, 0.21)
0.2–0.6 μg/L –0.05 (–0.31, 0.21)
> 0.6 μg/L 0.65
p for trend
LH (IU/L)b
< 0.2 μg/L 0
0.2–0.6 μg/L –0.12 (–0.33, 0.08)
> 0.6 μg/L 0.04 (–0.18, 0.26)
p for trend 0.99
Inhibin B (pg/mL)
< 0.2 μg/L 0
0.2–0.6 μg/L 0.81 (–35.3, 36.9)
> 0.6 μg/L 28.4 (–9.30, 66.0)
p for trend 0.18
FSH:inhibin B ratiob
< 0.2 μg/L 0
0.2–0.6 μg/L 0.07 (–0.42, 0.55)
> 0.6 μg/L –0.15 (–0.65, 0.36)
p for trend 0.66
T (ng/dL)
< 0.2 μg/L 0
0.2–0.6 μg/L –13.7 (–54.4, 27.0)
> 0.6 μg/L 37.6 (–4.74, 79.9)
p for trend 0.17
E2 (pg/mL)
< 0.2 μg/L 0
0.2–0.6 μg/L –0.70 (–6.05, 4.65)
> 0.6 μg/L –2.95 (–8.54, 2.63)
p for trend 0.32
SHBG (nmol/mL)b
< 0.2 μg/L 0
0.2–0.6 μg/L –0.11 (–0.26, 0.04)
> 0.6 μg/L –0.07 (–0.23, 0.09)
p for trend 0.24
FAIb
< 0.2 μg/L 0
0.2–0.6 μg/L 0.05 (–0.10, 0.19)
> 0.6 μg/L 0.15 (–0.003, 0.31)
p for trend 0.06
Free T (ng/dL)
< 0.2 μg/L 0
0.2–0.6 μg/L –0.28 (–1.26, 0.71)
> 0.6 μg/L 0.72 (–0.31, 1.75)
p for trend 0.29
T:LH ratiob
< 0.2 μg/L 0
0.2–0.6 μg/L 0.05 (–0.19, 0.30)
> 0.6 μg/L 0.04 (–0.22, 0.30)
p for trend 0.69
E2:T ratiob
< 0.2 μg/L 0
0.2–0.6 μg/L 0.06 (–0.19, 0.30)
> 0.6 μg/L –0.23 (–0.48, 0.03)
p for trend 0.15
Prolactin (ng/mL)b
< 0.2 μg/L 0
0.2–0.6 μg/L –0.004 (–0.18, 0.18)
> 0.6 μg/L –0.05 (–0.24, 0.14)
p for trend 0.62
Free T4 (ng/dL)
< 0.2 μg/L 0
0.2–0.6 μg/L –0.04 (–0.14, 0.05)
> 0.6 μg/L –0.003 (–0.10, 0.10)
p for trend 0.76
Measure
β-Coefficient  
(95% CI)
Total T3 (ng/mL)
< 0.2 μg/L 0
0.2–0.6 μg/L –0.01 (–0.07, 0.06)
> 0.6 μg/L 0.01 (–0.06, 0.08)
p for trend 0.86
TSH (μIU/mL)b
< 0.2 μg/L 0
0.2–0.6 μg/L –0.004 (–0.26, 0.26)
> 0.6 μg/L –0.12 (–0.39, 0.15)
p for trend 0.42
Semen quality and sperm DNA damagec
Total count (106)b
< 0.2 μg/L 0
0.2–0.6 μg/L –0.23 (–0.90, 0.43)
> 0.6 μg/L 0.18 (–0.49, 0.84)
p for trend 0.80
Concentration (106/mL)b
< 0.2 μg/L 0
0.2–0.6 μg/L –0.28 (–0.90, 0.33)
> 0.6 μg/L 0.20 (–0.34, 0.73)
p for trend 0.65
Motility (% motile)
< 0.2 μg/L 0
0.2–0.6 μg/L –1.33 (–12.0, 9.29)
> 0.6 μg/L 6.25 (–3.04, 15.5)
p for trend 0.24
Morphology (% normal)
< 0.2 μg/L 0
0.2–0.6 μg/L 0.60 (–1.56, 2.76)
> 0.6 μg/L 0.40 (–1.49, 2.28)
p for trend 0.61
VSL (μm/sec)
< 0.2 μg/L 0
0.2–0.6 μg/L –2.40 (–8.98, 4.17)
> 0.6 μg/L 3.99 (–1.75, 9.73)
p for trend 0.28
VCL (μm/sec)
< 0.2 μg/L 0
0.2–0.6 μg/L –5.57 (–16.7, 5.55)
> 0.6 μg/L 6.11 (–3.61, 15.8)
p for trend 0.37
Linearity (%)
< 0.2 μg/L 0
0.2–0.6 μg/L –6.71 (–13.4, –0.07)
> 0.6 μg/L –0.25 (–6.05, 5.55)
p for trend 0.58
Comet extent (μm)
< 0.2 μg/L 0
0.2–0.6 μg/L 1.38 (–22.1, 24.8)
> 0.6 μg/L 3.09 (–20.5, 26.6)
p for trend 0.79
TDM (μm)
< 0.2 μg/L 0
0.2–0.6 μg/L –1.10 (–8.97, 6.78)
> 0.6 μg/L –2.91 (–10.8, 5.00)
p for trend 0.46
Tail%
< 0.2 μg/L 0
0.2–0.6 μg/L 6.81 (–1.80, 15.4)
> 0.6 μg/L 8.23 (–0.41, 16.9)
p for trend 0.03
Table 4. Adjusted linear regression coefficients for change in hormone levels (n = 167), semen quality 
(n = 190), and sperm DNA damage measure (n = 137) associated with categories of urinary BP.
Abbreviations: CI, confidence interval; T, testosterone.
aAdjusted for SG, age, BMI, current smoking, and time of day of urine/serum/semen sample collection. bAdjusted for SG, 
age, BMI, abstinence period, current smoking, and time of urine sample. cModel included ln-transformations. Meeker et al.
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the results for BP were also consistent when 
modeling geometric mean or SG-corrected 
paraben concentrations (data not shown). 
Because we previously reported a positive asso-
ciation between urinary BPA concentration 
and Tail% in these same men (Meeker et al. 
2010b) and because BP and BPA may impart 
similar biological effects (e.g., estrogenic), we 
investigated the possibility of an inter  action 
between the two urinary biomarkers on Tail%. 
When we included both BP categories and 
BPA quartiles in the multi  variable model, 
both were associated with significant dose- 
dependent increases in Tail% (Figure 1). 
However, we found no evidence of inter-
action in stratified analyses or when including 
a BP × BPA inter  action term in the model 
(p = 0.25; data not shown), although the sta-
tistical power of the test for inter  action was 
low because of a fairly small sample size.
Discussion
As far as we are aware, this is the first human 
study to explore relationships between bio-
markers of paraben exposure and male 
reproductive health. With the exception of 
a suggestive inverse association between MP 
and TSH, and a suggestive positive associa-
tion between BP and FAI, we found no evi-
dence for a relationship between MP, PP, or 
BP and altered hormone levels or conventional 
semen quality parameters. For sperm DNA 
damage, we observed a suggestive inverse asso-
ciation between PP and TDM, a suggestive 
positive association between MP and Tail%, 
and a statistically significant positive associa-
tion between BP and Tail%. The relationship 
between BP and Tail% was not confounded by 
our recently reported relationship between uri-
nary BPA concentrations and Tail% and may 
suggest additive effects on Tail% in relation 
to combined exposures to both BP and BPA. 
We also found an inverse relationship between 
BMI and urinary paraben concentrations, 
which may reflect differences in exposure (e.g., 
product use, diet) and/or paraben metabolism 
between people with differing BMI.
Our observation that the only statistically 
significant relationship involved BP is consis-
tent with in vitro and animal data that suggest 
BP has greater reproductive toxicity poten-
tial than the other parabens examined in this 
study (Darbre and Harvey 2008; Golden et al. 
2005). However, we did not observe inverse 
relationships between BP and sperm concen-
tration and testosterone, which were reported 
in sub  chronic studies of rodents exposed to BP 
at around 4 weeks of age (Oishi 2001, 2002a) 
or in utero (Kang et al. 2002). Studies inves-
tigating whether BP causes DNA damage are 
limited, although BP has been associated with 
geno  toxicity in CHO-K1 Chinese hamster 
ovary cells (Tayama et al. 2008) and increased 
cell death and injury in rat hepatocytes 
[National Toxicology Program (NTP) 2004]. 
Our observation of a positive association with 
sperm DNA damage, as measured by Tail%, 
may also be consistent with previous reports 
that BP may be a suitable vaginal contracep-
tive because of its ability to inhibit acrosin (an 
enzyme that aids sperm penetration into the 
oocyte during the fertilization process), most 
likely by damaging the sperm membrane (Song 
et al. 1991, 1989). For example, the primary 
cause of sperm DNA damage is likely to be oxi-
dative stress (Aitken and De Iuliis 2010; Aitken 
et al. 2009), which can also damage the sperm 
membrane (Sharma et al. 2004). Although not 
well studied, parabens caused oxidative stress 
in skin cells (Nishizawa et al. 2006), and BP 
was associated with decreased cellular levels of 
glutathione and protein-sulfhydryl groups in 
rat hepatocytes (NTP 2004).
Although it is currently unclear which 
comet assay parameter is the most relevant 
measure of sperm DNA damage, Tail% has 
been shown to be proportional to the fre-
quency of DNA strand breaks (Olive et al. 
1990). Tail% may also represent a more sensi-
tive measure of DNA damage than both TDM 
and comet extent, because Tail% continues to 
increase with increased DNA damage whereas 
comet extent may not (McKelvey-Martin 
et al. 1993). Inconsistent results between the 
various DNA damage meas  ures obtained by 
the neutral comet assay regressed on the same 
independent variable have been observed in 
previous studies (Meeker et al. 2004b). It has 
been hypothe  sized that the different comet 
assay parameters may reflect different types 
of DNA strand breaks (Meeker et al. 2004b): 
Specifically, because of the lack of correlation 
between TDM and Tail%, a high TDM may 
be more likely to be associated with double-
strand breaks, whereas a high Tail% may reflect 
single-strand breaks. Thus, in the present study, 
BP was positively associated with Tail%, which 
may reflect a relation  ship between BP and sin-
gle-strand breaks. However, it is possible that 
this relationship was a chance finding in our 
data, and future research is needed in order to 
confirm our results.
Paraben exposures in the present study 
were likely representative of those found among 
men in the U.S. general population. Median 
and 95th percentile concentrations recently 
reported in males participating in the National 
Health and Nutrition Examination Survey 
(NHANES) for 2005–2006 (Calafat et al. 
2010) were, respectively, 23.7 and 491 µg/L 
for MP, 2.3 and 125 µg/L for PP, and < LOD 
and 3.2 µg/L for BP, compared with 27.4 and 
258 µg/L for MP, 3.5 and 95.5 µg/L for PP, 
and < LOD and 4.1 µg/L for BP in the present 
study. It should be noted that paraben exposure 
was much higher among women than among 
men in NHANES; females had 75th percentile 
urinary MP, PP, and BP concentrations that 
were 4, 7, and 12 times higher, respectively, 
than those of males (Calafat et al. 2010). Thus, 
human epidemiologic studies of female repro-
ductive effects and adverse pregnancy outcomes 
in relation to paraben exposure should also be 
conducted.
We believe the present study is also the 
first to assess the temporal variability of para-
ben concentrations in urine. MP and PP con-
centrations were weakly correlated in repeated 
urine samples collected from the same indi-
viduals and had low ICCs (≤ 0.35). Repeated 
BP concentrations were moderately correlated. 
These measures of temporal reliability were 
greater than for urinary BPA concentrations 
among these men (Meeker et al. 2010a) but 
less than for concentrations of urinary metab-
olites of phthalates and non  persistent pesti-
cides among a different subset of men from 
the ongoing study (Hauser et al. 2004; Meeker 
et al. 2005). Thus, the lack of an association 
between urinary parabens and hormone lev-
els or semen quality in the present study may 
be due to the presence of non  differential 
Figure 1. Adjusted linear regression coefficients [95% confidence interval (CI)] for change in Tail% associated 
with categories of urinary BP and BPA included in the same model, adjusted for SG, age, BMI, abstinence 
period, current smoking, and time of collection of urine sample (n = 132). 
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(random) measurement error in our exposure 
estimates. Future studies should measure para-
ben concentrations in multiple urine samples 
collected over the exposure window of interest 
to reduce exposure measurement error. In the 
present study, the use of the geometric mean of 
repeated urinary paraben concentrations, when 
available, generally resulted in weaker asso-
ciations with reproductive measures. This was 
consistent with our recent analysis of urinary 
BPA among these men (Meeker et al. 2010b). 
However, this may be because we collected the 
repeated urine samples weeks or months after 
the serum/semen samples used for measur-
ing hormone levels, semen quality, and sperm 
DNA damage, whereas the exposure window 
of interest would likely be weeks or months 
leading up to the assessment of these measures.
The present study had a number of other 
limitations in addition to the likely presence 
of high temporal variability in paraben expo-
sure levels. This includes the availability of 
only a single blood or semen sample for the 
assessment of hormone levels, semen quality, 
and sperm DNA damage, which may also 
vary over time. The cross-sectional design of 
the present analysis also restricts our ability 
to make conclusions regarding causal rela-
tionships, and the relatively small sample size 
provided low statistical power, which lim-
ited our ability to detect subtle relationships 
between urinary parabens and male reproduc-
tive health markers. For example, we observed 
adjusted regression coefficients of –0.08 and 
–0.06 for the relationships between sperm 
concentration and MP or PP, respectively. 
With our sample size of 190, we would have 
had 80% power to detect (α = 0.05) adjusted 
regression coefficients of approximately –0.22 
and –0.15, respectively (Lenth 2009). Finally, 
because of the study’s exploratory nature, we 
made a large number of statistical compari-
sons. Thus, we cannot rule out the possibility 
of chance findings to explain the observed 
relationship between BP and Tail%.
Conclusion
We found limited to no evidence of a relation-
ship between paraben concentrations in urine 
and hormone levels or conventional semen 
quality parameters. However, it is possible 
that intra  individual variability in exposure 
and a modest sample size could have lim-
ited our ability to detect subtle relationships. 
Our observation of a relation  ship between BP 
and sperm DNA damage, in addition to the 
potential for additive effects from combined 
exposures to BP and BPA, warrants further 
investigation. Added research on the poten-
tial for additive or multiplicative interactions 
between exposures to multiple environmental 
agents on male reproduction is also needed.
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